The easiest category to uplist to NASDAQ would be
Post# of 144902
![Avatar](/images/ProfileImages/947101588_48586_morph.jpg)
![210320079_market.jpg](https://investorshangout.com/images/MYImages/210320079_market.jpg)
The best IMO would be the Capital Market, Market value. The share price needs to be above $2 for 90 days, but it needs 4M in shareholder equity. The shareholder’s equity went from -13M last may to -8M in November, I assume from the pre-inventory build-up. Once the drug is approved, I believe from looking at GILD for example, but I’m not 100% sure, this the will show up as inventory at market value, i.e, 200M, which should push the shareholder equity way above the needed requirement.
![986727734_Cmarket.jpg](https://investorshangout.com/images/MYImages/986727734_Cmarket.jpg)
![1556829611_se.jpg](https://investorshangout.com/images/MYImages/1556829611_se.jpg)
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)